BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 793553)

  • 1. Immunotherapy in the management of myelogenous leukemia.
    Fairley GH
    Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of immunotherapy in acute myelogenous leukemia.
    Foon KA; Smalley RV; Riggs CW; Gale RP
    Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy in acute leukemias. Possible applications in children.
    Mahoney DH; Starling KA
    Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of acute myelogenous leukemia in man.
    Powles R
    Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of leukemia and lymphoma.
    Murphy S; Hersh E
    Semin Hematol; 1978 Apr; 15(2):181-203. PubMed ID: 418506
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
    Powles R; Toy JL
    Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical immunotherapy experiences in the Southeastern Cancer Study Group.
    Gordon DS
    Dev Biol Stand; 1977 Apr 13-15; 38():567-72. PubMed ID: 344110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R
    Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunology and immunotherapy of leukemia (basic results of 8-years research)].
    Bergol'ts VM
    Vopr Onkol; 1978; 24(11):16-24. PubMed ID: 283626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy of acute myelogenous leukemia (AML) in adults with the Nocardia rubra cell wall skeleton].
    Ohno R; Nakamura H; Kodera Y; Masaoka T; Yamada K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1264-9. PubMed ID: 3524463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia.
    Alsabti EA; Taleb AM; Raji HM; Kalil OZ; Saleh KA
    Jpn J Exp Med; 1979 Jun; 49(3):157-68. PubMed ID: 385948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemo-immunotherapy versus chemotherapy in acute myeloid leukemia. Preliminary results.
    Fiere D; Doillon M; Martin C; Vu Van T; Revol L
    Biomedicine; 1976 Dec; 25(9):318. PubMed ID: 1069595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of immunotherapy of acute leukemias with BCG vaccine of Polish production].
    Kardaszewicz E; Japa J
    Acta Haematol Pol; 1975; 6(2):149-55. PubMed ID: 1057344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG in the therapy of cancer.
    Delmonte L; Oettgen HF
    Clin Bull; 1975; 5(2):69-71. PubMed ID: 776445
    [No Abstract]   [Full Text] [Related]  

  • 16. [BCG and irradiated allogenic blast cells in maintenance chemotherapy of children with acute lymphoblastic leukemia in remission. A controlled study].
    Ortega JJ; Javier G
    Sangre (Barc); 1982; 27(3):349-57. PubMed ID: 6760428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?].
    Mathé G; Misset JL; Machover D; Schwarzenberg L; Timus M; Jasmin C; Ribaud P; Musset M
    Biomed Pharmacother; 1984; 38(1):13-32. PubMed ID: 6380605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG and cancer.
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(26):1458-69. PubMed ID: 4598691
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
    Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems of cancer immunotherapy (author's transl)].
    Gericke D
    MMW Munch Med Wochenschr; 1977 Nov; 119(46):1497-1500. PubMed ID: 414081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.